| Literature DB >> 34047653 |
Serena Simoni1, Marina Mingoia2, Andrea Brenciani2, Maria Carelli3, Maria M Lleò3, Giovanni Malerba4, Carla Vignaroli1.
Abstract
We report a novel IncHI2 plasmid coharboring blaVIM-1, two copies of blaKPC-3, and mcr-9.1 resistance genes in a human Escherichia coli isolate of the new serogroup O188. The blaVIM-1 gene was included in a class 1 integron, mcr-9.1 in a cassette bracketed by IS903 and ΔIS1R, and blaKPC-3 in two copies within a new composite Tn4401-like transposon. The emergence of carbapenem and colistin resistance genes in a single plasmid is of great concern for upcoming clinical therapies.Entities:
Keywords: Escherichia coli; IncHI2 plasmid; carbapenems; colistin; multidrug resistance
Mesh:
Substances:
Year: 2021 PMID: 34047653 PMCID: PMC8265643 DOI: 10.1128/mSphere.00302-21
Source DB: PubMed Journal: mSphere ISSN: 2379-5042 Impact factor: 4.389
FIG 1Genetic characterization of the IncHI2 plasmid pEC3. Circular map of the pEC3 plasmid coharboring mcr-9.1, blaVIM-1, and blaKPC-3 in comparison with similar reported plasmids using BRIG software. The plasmids included in the analysis were as follows: (inner to outer circles) pRH-R27 (GenBank ID LN555650), pECAZ147_KPC (CP018992), pME-1a (CP041734), and pMS37a (CP053191). Black arrows indicate the positions and orientations of genes; some resistance and relevant genes described in this study are shown.
FIG 2(a to c) Linear comparison of the blaKPC-3, blaVIM-1, and mcr-9.1 contexts of pEC3 with the corresponding regions of highly similar plasmids pECAZ147_KPC and pRH-R27. Gray shading indicates regions of shared homology (ranging from 92 or 96% to 100%). The three resistance genes under study are shown by red arrows.